Aug 30 (Reuters) - Angion Biomedica Corp ANGN.O :
* ANGION BIOMEDICA CORP SAYS ON AUGUST 27, CO RECEIVED
WRITTEN
NOTICE FROM SINOVANT SCIENCES HK LIMITED - SEC FILING
* ANGION BIOMEDICA CORP - ON NOV 25, SINOVANT SCIENCES HK
LTD
INTENDS TO TERMINATE EXCLUSIVE LICENSE AGREEMENT WITH CO DATED
AUGUST 22, 2018
* ANGION BIOMEDICA CORP - NO FEES, PAYMENTS, OR OTHER
FINANCIAL
REMUNERATION DUE TO EITHER ANGION OR SINOVANT RESULTING FROM
TERMINATION OF AGREEMENT
* ANGION BIOMEDICA CORP - EVALUATING STRATEGIC OPTIONS TO
MAXIMIZE
VALUE OF CLINICAL DEVELOPMENT, COMMERCIALIZATION RIGHTS FOR
ANG-3777 IN GREATER CHINA
Further company coverage: ANGN.O
((Reuters.Briefs@thomsonreuters.com;))